User profiles for William Hu
William T HuAssociate professor, Rutgers Biomedical and Health Sciences Verified email at rutgers.edu Cited by 9720 |
[HTML][HTML] Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
A wide spectrum of clinical manifestations has become a hallmark of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the …
Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke
…, AM Demchuk, ME Hudon, WY Hu… - American Journal …, 2001 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Clinicians are insecure reading CT scans by using the
one-third rule for acute middle cerebral artery stroke (1/3 MCA rule) before treating patients with …
one-third rule for acute middle cerebral artery stroke (1/3 MCA rule) before treating patients with …
Serum glucose level and diabetes predict tissue plasminogen activator–related intracerebral hemorrhage in acute ischemic stroke
…, LB Morgenstern, DW Krieger, T Linda Chi, W Hu… - Stroke, 1999 - Am Heart Assoc
Background and Purpose—Five pretreatment variables (P<0.1 univariate analysis), including
serum glucose (>300 mg/dL), predicted symptomatic intracerebral hemorrhage (ICH) in the …
serum glucose (>300 mg/dL), predicted symptomatic intracerebral hemorrhage (ICH) in the …
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Neurofibrillary tangles (NFTs), composed of truncated and hyperphosphorylated tau, are a
common feature of numerous aging-related neurodegenerative diseases, including …
common feature of numerous aging-related neurodegenerative diseases, including …
Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score
…, A Krol, C O'Reilly, ME Hudon, WY Hu… - … Journal of Stroke, 2008 - journals.sagepub.com
Background In ischemic stroke, functional outcomes vary depending on site of intracranial
occlusion. We tested the prognostic value of a semiquantitative computed tomography …
occlusion. We tested the prognostic value of a semiquantitative computed tomography …
The future of blood-based biomarkers for Alzheimer's disease
Abstract Treatment of Alzheimer's disease (AD) is significantly hampered by the lack of easily
accessible biomarkers that can detect disease presence and predict disease risk reliably. …
accessible biomarkers that can detect disease presence and predict disease risk reliably. …
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin… - Neurology, 2012 - AAN Enterprises
Objectives: While plasma biomarkers have been proposed to aid in the clinical diagnosis of
Alzheimer disease (AD), few biomarkers have been validated in independent patient cohorts…
Alzheimer disease (AD), few biomarkers have been validated in independent patient cohorts…
[HTML][HTML] Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020
…, RF Schinazi, ME Mullins, WT Hu - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
There are few detailed investigations of neurologic complications in severe acute
respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed …
respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed …
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
KA Josephs, JL Whitwell, DS Knopman, WT Hu… - Neurology, 2008 - AAN Enterprises
Background: TAR DNA-binding protein 43 (TDP-43) is one of the major disease proteins in
frontotemporal lobar degeneration with ubiquitin immunoreactivity. Approximately one-fourth …
frontotemporal lobar degeneration with ubiquitin immunoreactivity. Approximately one-fourth …
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis
…, M Grossman, JD Berry, WT Hu… - Science translational …, 2017 - science.org
There is no effective treatment for amyotrophic lateral sclerosis (ALS), a devastating motor
neuron disease. However, discovery of a G 4 C 2 repeat expansion in the C9ORF72 gene as …
neuron disease. However, discovery of a G 4 C 2 repeat expansion in the C9ORF72 gene as …